[
    [
        {
            "time": "2018-09-28",
            "original_text": "康泰生物(300601.SZ)半年度权益分派10派3元 股权登记日为9月28日",
            "features": {
                "keywords": [
                    "康泰生物",
                    "权益分派",
                    "股权登记日"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "康泰生物(300601.SZ)半年度权益分派10派3元 股权登记日为9月28日",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-09-28",
            "original_text": "控股股东减持后呼吁员工兜底增持，康泰生物“葫芦里卖什么药”？ 减持股份",
            "features": {
                "keywords": [
                    "控股股东",
                    "减持",
                    "兜底增持",
                    "康泰生物"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "控股股东减持后呼吁员工兜底增持，康泰生物“葫芦里卖什么药”？ 减持股份",
                "Correlation": 10,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-09-29",
            "original_text": "康泰生物(300601.SZ)拟10股派3元 9月29日除权除息",
            "features": {
                "keywords": [
                    "康泰生物",
                    "除权除息",
                    "分红"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "康泰生物(300601.SZ)拟10股派3元 9月29日除权除息",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-09-28",
            "original_text": "康泰生物：对关注函的回复正在准备中丨公司问答 关注函",
            "features": {
                "keywords": [
                    "康泰生物",
                    "关注函",
                    "回复"
                ],
                "sentiment_score": 0.0,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "康泰生物：对关注函的回复正在准备中丨公司问答 关注函",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-09-28",
            "original_text": "实控人发“兜底”增持倡议，康泰生物收深交所发函追问 问询",
            "features": {
                "keywords": [
                    "实控人",
                    "兜底增持",
                    "深交所",
                    "问询"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "实控人发“兜底”增持倡议，康泰生物收深交所发函追问 问询",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-09-28",
            "original_text": "康泰生物收函：实控人鼓励员工增持，自己却先套现逾9千万？ 减持股份数量",
            "features": {
                "keywords": [
                    "康泰生物",
                    "实控人",
                    "增持",
                    "套现"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "康泰生物收函：实控人鼓励员工增持，自己却先套现逾9千万？ 减持股份数量",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        }
    ]
]